Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges.
Saved in:
| Title: | Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges. |
|---|---|
| Authors: | Edmondson SD; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA. Electronic address: scott.edmondson@astrazeneca.com., Yang B; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA., Fallan C; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK. |
| Source: | Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Jul 01; Vol. 29 (13), pp. 1555-1564. Date of Electronic Publication: 2019 Apr 20. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31047748 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Edmondson+SD%22">Edmondson SD</searchLink>; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA. Electronic address: scott.edmondson@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Yang+B%22">Yang B</searchLink>; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fallan+C%22">Fallan C</searchLink>; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107377%22">Bioorganic & medicinal chemistry letters</searchLink> [Bioorg Med Chem Lett] 2019 Jul 01; Vol. 29 (13), pp. 1555-1564. <i>Date of Electronic Publication: </i>2019 Apr 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9107377 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1464-3405 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220960894X%22">0960894X </searchLink><i>NLM ISO Abbreviation: </i>Bioorg Med Chem Lett <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31047748 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bmcl.2019.04.030 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1555 Titles: – TitleFull: Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Edmondson SD – PersonEntity: Name: NameFull: Yang B – PersonEntity: Name: NameFull: Fallan C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2019 Jul 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1464-3405 Numbering: – Type: volume Value: 29 – Type: issue Value: 13 Titles: – TitleFull: Bioorganic & medicinal chemistry letters Type: main |
| ResultId | 1 |
